PDCline Pharma SAS Company

PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells.
Industry: Genomic and Epigenominc Instabillity
Headquarters: France
Visit Website
contact@pdc-line-pharma.com
Register and Claim Ownership